#1 Clinical Trials Search in Europe

Retinol Palmitate

This article examines the use of Retinol Palmitate, a form of vitamin A, in clinical trials for various health conditions. Researchers are investigating its potential benefits in eye disorders, immune system modulation, and neurological diseases. The trials aim to assess the efficacy and safety of Retinol Palmitate supplementation in different patient populations.

Table of Contents

What is Retinol Palmitate?

Retinol palmitate is a form of vitamin A that is commonly used in medical treatments and skincare products. It is also known by other names such as vitamin A palmitate, retinyl palmitate, and Aquasol A[1]. This compound is created by combining retinol (pure vitamin A) with palmitic acid, which helps stabilize the vitamin and allows it to be stored in the body[2].

Medical Uses

Retinol palmitate is being studied and used for various medical conditions, including:

  • Eye disorders: It is being investigated for treating reticular pseudodrusen (RPD) and age-related macular degeneration (AMD), which are eye conditions that can cause vision problems[2][3].
  • Premature infants: It is used to supplement very low birth weight babies who may have low vitamin A levels, potentially improving eye and lung development[1].
  • Vitamin A deficiency: It can be used to treat and prevent vitamin A deficiency, which can affect various body functions, including vision and immune system health[4].
  • Skin conditions: In skincare, it is used to improve the appearance of wrinkles and pigmentation associated with aging[5].

How It’s Administered

Retinol palmitate can be given in several ways, depending on the condition being treated:

  • Oral supplements: It can be taken by mouth in capsule form. Doses vary widely, from 16,000 IU to 400,000 IU, depending on the condition and patient age[2][4].
  • Intramuscular injections: For premature infants, it may be given as an injection into the muscle, typically at a dose of 10,000 IU three times weekly[1].
  • Topical application: In skincare, it is applied directly to the skin, often in a cream or lotion form[5].

Potential Benefits

Research suggests that retinol palmitate may offer several benefits:

  • Improved eye health: It may help improve dark adaptation (the ability of the eye to adjust to low light conditions) in people with certain eye disorders[2][3].
  • Better outcomes for premature infants: Supplementation may improve retinal function and overall health in very low birth weight babies[1].
  • Enhanced immune function: In HIV-positive mothers, it may help reduce mother-to-child transmission of HIV during breastfeeding[4].
  • Skin improvements: When applied topically, it may help reduce the appearance of wrinkles and improve skin pigmentation[5].

Side Effects and Precautions

While retinol palmitate is generally considered safe when used as directed, it can cause some side effects:

  • Skin irritation: When applied topically, it may cause redness, dryness, or peeling of the skin[5].
  • Vitamin A toxicity: High doses, especially when taken orally, can lead to vitamin A toxicity. Symptoms may include nausea, headaches, blurred vision, and in severe cases, liver damage[1].
  • Pregnancy concerns: High doses of vitamin A during pregnancy may cause birth defects. Pregnant women should consult their doctor before taking vitamin A supplements.

Ongoing Research

Several clinical trials are currently investigating the effects of retinol palmitate:

  • Its potential to improve eye function in people with reticular pseudodrusen and age-related macular degeneration[2][3].
  • Its effects on very low birth weight premature infants[1].
  • Its impact on HIV transmission and infant mortality in developing countries[4].
  • Its effectiveness compared to other compounds (like bakuchiol) in improving skin appearance[5].

These studies aim to better understand how retinol palmitate works and to determine the most effective and safe ways to use it in various medical conditions.

Condition Study Type Intervention Key Outcomes
Age-related Macular Degeneration & Reticular Pseudodrusen Pilot, uncontrolled Oral Vitamin A Palmitate (16,000 IU or 48,000 IU daily) Changes in dark adaptation, low luminance visual acuity, patient-reported outcomes
Acne Vulgaris Split-face comparative Topical Retinyl Palmitate-loaded ethosomes Efficacy in reducing acne lesions, tolerability compared to conventional retinoids
Latent Tuberculosis Randomized, placebo-controlled Oral Vitamin A (200,000 IU at intervals) Changes in immune responses to mycobacterial antigens, progression to clinical disease
Preterm Birth & Retinopathy of Prematurity Randomized, partially blinded Intramuscular Vitamin A (10,000 IU three times weekly) Retinal function, plasma levels of vitamin A, hepatic stores of vitamin A
Multiple Sclerosis Randomized, placebo-controlled Oral Vitamin A (25,000 IU daily) Changes in retinoic acid receptor gene expression in immune cells

FAQ

  • What is Retinol Palmitate? Retinol Palmitate is a form of vitamin A used in clinical trials. It is a fat-soluble vitamin that plays important roles in eye health, immune function, and cell growth.
  • What conditions are being studied with Retinol Palmitate? Clinical trials are investigating Retinol Palmitate for conditions such as age-related macular degeneration, reticular pseudodrusen, acne vulgaris, latent tuberculosis, preterm birth complications, and multiple sclerosis.
  • How is Retinol Palmitate administered in these trials? Administration methods vary by study, including oral supplements, intramuscular injections, and topical applications. Dosages and frequency also differ based on the condition being treated and the patient population.
  • Are there any potential side effects of Retinol Palmitate supplementation? While generally considered safe at recommended doses, high doses of vitamin A can have side effects. Trials monitor for signs of toxicity, which may include skin changes, bone and joint abnormalities, or liver function changes.
  • How long do these clinical trials typically last? The duration of trials varies widely, ranging from a few months to several years. Some studies involve a single dose, while others investigate long-term supplementation effects.

Ongoing Clinical Trials on Retinol Palmitate

  • Study on the Early Use of Levosimendan Compared to Placebo for Patients with Cardiogenic Shock

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

  • Evaluation of Retinol Palmitate Administration and Serum Levels in Preterm Infants with Bronchopulmonary Dysplasia: A Phase 2a Open-Label Study

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland

Glossary

  • Retinol Palmitate: A form of vitamin A used in supplements and clinical trials, also known as vitamin A palmitate.
  • Age-related Macular Degeneration (AMD): An eye disease that is a leading cause of vision loss in people over 55, affecting the central part of the retina called the macula.
  • Reticular Pseudodrusen (RPD): A retinal finding associated with age-related macular degeneration, characterized by yellowish deposits beneath the retina.
  • Dark Adaptation: The process by which the eye adjusts to low light conditions, often impaired in certain eye disorders.
  • Acne Vulgaris: A common skin condition characterized by pimples, typically occurring on the face, chest, and back.
  • Latent Tuberculosis Infection (LTBI): A condition in which a person is infected with Mycobacterium tuberculosis but does not have active tuberculosis disease.
  • Retinopathy of Prematurity (ROP): An eye disorder that primarily affects premature infants, potentially leading to vision loss.
  • Multiple Sclerosis (MS): A chronic inflammatory disease of the central nervous system that affects the brain, spinal cord, and optic nerves.
  • Electroretinogram (ERG): A diagnostic test that measures the electrical responses of various cell types in the retina.
  • Retinoic Acid Receptor (RAR): A type of nuclear receptor that binds retinoic acid, a metabolite of vitamin A, and regulates gene expression.

References

  1. https://clinicaltrials.gov/study/NCT00417404
  2. https://clinicaltrials.gov/study/NCT03478878
  3. https://clinicaltrials.gov/study/NCT03478865
  4. https://clinicaltrials.gov/study/NCT00198718
  5. https://clinicaltrials.gov/study/NCT03112863